A powerful unparalleled AI engine

LENSai™ Integrated Intelligence Platform

At the forefront of healthcare innovation lies our powerful technology, which is designed to accelerate drug discovery by delivering scalable data visualization and insights.  It helps researchers rapidly identify novel therapeutic targets and life-changing drug candidates while also enabling personalized medicine for individual patients.  With the synergistic combination of cutting-edge technology and laboratory expertise, LENSai’s self-learning systems is developed to transform your discovery process. Join us in our mission to revolutionize healthcare and improve the lives of patients around the world.

Disruption
at scale

The power of LENSai: actionable insight

Rapid insight and critical analysis

Our platform provides rapid access to meaningful insights that help identify novel and complex targets, analyze data, and optimize antibody sequences. Our knowledge graphs support every step in the process, accelerating end-to-end clinical discovery.

Discover hidden knowledge

By analyzing diverse data sources, LENSai is designed to identify new antibody targets, predict binding affinities, optimize antibody sequences, amplify diversity in discovery, predict potential side effects, and immunogenicity in therapeutic applications.

Benchmark lead candidates

Rapidly screen a large number of lead candidates to help predict their efficacy and identify potential safety concerns, aiming at prioritizing your most promising lead candidates for further development.

Build knowledge base

Active learning continuously builds and indexes sequence data, and links it with relevant metadata, creating a centralized and efficient knowledge base that is instantly available and traceable.

Analyze at
scale

Designed to enable researchers to analyze large-scale, multi-dimensional and multi-source omics data in real-time, gaining deeper insights into biological systems and accelerating the development of new therapies and diagnostics.

Unified user platform

HYFTs® - our universal language for biological data—unifies, organizes, and standardizes multi-omics data. It is designed to enable you and your team to collaborate and perform efficient, accurate analyses. It works across all species and is applicable in any phase.

The power within: deep scalability

A deeper understanding of the biosphere starts with access to a powerful knowledge graph. The richer the graph, the more detailed and actionable the insights. With 25 billion biologic connections, the HYFT graph unlocks fine-grained exploration, revealing relationships and driving discovery at deep scale.

Connecting the biosphere

Introducing LENSai - the first-in-class patented HYFT technology’s distinctive ability to link sequence, structure, function, and literature in makes it an invaluable tool for generating new insights and propelling scientific research forward. The powerful and robust technology provides a comprehensive understanding of the relationships between genes, proteins, and biological pathways, enabling the identification of novel targets for drug discovery and development. Integrating proprietary algorithms into their Large Language Model (LLM), this technology is designed to offer the following benefits: enhanced natural language understanding, advanced biological data mining, hypothesis generation, improved predictive modeling, enhanced decision support, and streamlined knowledge integration.
Connecting the biosphere

Continuous learning, high-throughput indexing

Unlock the power of continuous innovation with a self-learning platform that evolves alongside scientific discovery. Ongoing data enrichment and looping help refine accuracy and expand the knowledge base, supporting access to the latest insights. Whether identifying potential genetic variants linked to disease, benchmarking candidates, analyzing drug efficacy, or uncovering the mechanisms behind complex diseases, our dynamic platform is designed to fuel deep exploration and informed decision-making. The future of discovery starts here.

Continuous learning, high-throughput indexing
Cracking the genome code - HYFTs Universal Fingerprints™
HYFT technology uses unique patterns or “Universal Fingerprints” found in nature to create a vast network of connections that help us understand the complex relations within biological systems. Unlike other technologies, the unique feature of HYFTs is its ability to connect crucial dimensions in biology in one network such as sequence information (DNA, RNA or amino acids), 3D structures of proteins, functional information and text-based scientific literature. Additionally, the combination of HYFT technology with cutting-edge AI advancements like Large Language Models (LLMs) and 3D protein structure prediction capabilities from AlphaFold-2, an artificial intelligence tool developed by DeepMind (an Alphabet company specializing in AI), along with ESM-2, an innovative approach developed by Meta AI researchers for protein structure prediction, forms an exceptionally powerful system for our AI-driven learning platform.
20 million Integrated structural HYFTs
660 million Indexed data objects
25+ billion Biosphere data correlations
Markets
Rapidly evolving with expanding capabilities
  • Biotherapeutic discovery
  • Veterinary therapeutics
  • Agriculture, horticulture, crop protection solutions
Service
offering
Cracking the code: built for unprecedented insight and analysis
Designed to help: accelerate drug discovery, lower costs, improve efficiency, expand data insight, enhance safety and efficacy. Scale LENSai to customize to your needs and promote end-to-end high-throughput workflows.
Data Management
Data Management
Data Organization
Data
Lineage
Metadata
Management
Multi-interface (API-first)
Sequence Analysis
Sequence Analysis
Variant Calling
Immune Repertoire Analysis
Immunogenicity Screening
Affinity Maturation
Structural Analysis
Structural Analysis
Epitope Prediction
Antibody Structure Prediction
Epitope Binning
Structural Modeling
Ligand Docking
Functional Analysis
Functional Analysis
Target Validation
Functional Profiling
Lead Identification
Target Discovery
Biosimilars
Customized cross-functional analysis
The unparalleled functionality can be customized to combine cross-functional layering and analysis of sequence, structure, and function allowing for a truly comprehensive and integrated approach to understanding complex biological systems.

When we push boundaries we advance.
Let's accelerate discovery.

Partner with us

Let’s accelerate discovery

Learn more about our portfolio, pipeline, and career opportunities.

Ingrid Brands, Ph.D
General Manager